| 1 |
Inclisiran: a new generation of lipid-lowering siRNA therapeutic |
|
| | Yanzhen Zhang, Huaigang Chen, Lang Hong, Hong Wang, Bin Li, Mengyin Zhang, Jiamei Li, Liu Yang, Fan Liu | | | Frontiers in Pharmacology. 2023; 14 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Plasma Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) as a Possible Biomarker for Severe COVID-19 |
|
| | Patricia Mester, Pablo Amend, Stephan Schmid, Martina Müller, Christa Buechler, Vlad Pavel | | | Viruses. 2023; 15(7): 1511 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations |
|
| | Isabella Hetherington, Hana Totary-Jain | | | Molecular Therapy. 2022; | | | [Pubmed] [Google Scholar] [DOI] | |
|
